Wolverine Asset Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$325K Sell
30,037
-7,000
-19% -$62.7K ﹤0.01% 1092
2026
Q2
$349K Buy
+37,037
New +$332K ﹤0.01% 1017
2024
Q1
– Sell
-22,767
Closed -$106K – 1837
2023
Q4
$109K Hold
22,767
– – ﹤0.01% 1119
2023
Q3
$165K Sell
22,767
-35,383
-61% -$283K ﹤0.01% 1072
2023
Q2
$432K Sell
58,150
-291,850
-83% -$2.3M 0.01% 875
2023
Q1
$2.43M Buy
+350,000
New +$3.22M 0.03% 474
2022
Q4
– Sell
-65,038
Closed -$1.15M – 2249
2022
Q3
$1.18M Buy
+65,038
New +$2.82M 0.01% 740
2021
Q3
– Sell
-666
Closed -$147K – 2238
2021
Q2
$141K Buy
+666
New +$122K ﹤0.01% 1373
2020
Q4
– Sell
-2,787
Closed -$296K – 1816
2020
Q3
$301K Buy
+2,787
New +$340K ﹤0.01% 870
2020
Q2
– Sell
-7,437
Closed -$284K – 1706
2020
Q1
$100K Sell
7,437
-6,995
-48% -$59.2K ﹤0.01% 1046
2019
Q4
$57K Buy
+14,432
New +$62.6K ﹤0.01% 1172
2019
Q2
– Sell
-4,256
Closed -$33.5K – 1553
2019
Q1
$46K Buy
4,256
+576
+16% +$18.2K ﹤0.01% 1190
2018
Q4
$135K Buy
+3,680
New +$143K ﹤0.01% 1310

Other funds holding NVAX

Wolverine Asset Management's NVAX Position: Q3 2026 in Review

Wolverine Asset Management reduced its Novavax (NVAX) stake by 19% in Q3 2026, selling an estimated $62.7K and leaving 30,037 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #1092.

Wolverine Asset Management first reported a position in NVAX in Q4 2018 and has held it in 13 quarters since. The position peaked at $2.43M in Q1 2023. 220 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

  • Wolverine Asset Management held 30,037 shares of Novavax worth $325K as of Q3 2026.
  • Wolverine Asset Management sold 7,000 Novavax shares in Q3 2026, an estimated $62.7K.
  • Novavax made up ﹤0.01% of Wolverine Asset Management's portfolio in Q3 2026, its #1092 holding.
  • Wolverine Asset Management first reported a position in Novavax in Q4 2018 and has held it in 13 quarters since.
  • Wolverine Asset Management's Novavax position peaked at $2.43M in Q1 2023.
  • 220 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on Wolverine Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.